{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:05:36Z","timestamp":1777633536360,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100026749","name":"Bar Association of San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100026749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xphs.2024.06.023","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T01:32:22Z","timestamp":1720229542000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantification of soluplus for dissolution tests: SEC method development and validation"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9413-2355","authenticated-orcid":false,"given":"Zolt\u00e1n M\u00e1rk","family":"Horv\u00e1th","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liga","family":"Petersone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-3470","authenticated-orcid":false,"given":"Valentyn","family":"Mohylyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2024.06.023_bib0001","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acs.bioconjchem.7b00646","article-title":"Advances in polymer design for enhancing oral drug solubility and delivery","volume":"29","author":"Ting","year":"2018","journal-title":"Bioconjug Chem"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.023_bib0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/10717544.2019.1704940","article-title":"Mechanisms of increased bioavailability through amorphous solid dispersions: a review","volume":"27","author":"Schittny","year":"2020","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.023_bib0003","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the dissolution mechanism of ritonavir-copovidone amorphous solid dispersions: importance of congruent release for enhanced performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.06.023_bib0004","article-title":"Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: effect of formulation and process parameters for a low glass transition temperature drug","volume":"58","author":"Kallakunta","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2024.06.023_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2015.06.004","article-title":"Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers","volume":"211","author":"Sun","year":"2015","journal-title":"J Control Rel"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.06.023_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijpharm.2015.02.035","article-title":"Identifying the mechanisms of drug release from amorphous solid dispersions using MRI and ATR-FTIR spectroscopic imaging","volume":"483","author":"Puncochova","year":"2015","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.023_bib0007","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejpb.2006.11.020","article-title":"Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions","volume":"66","author":"Karavas","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2024.06.023_bib0008","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.colsurfb.2012.11.020","article-title":"The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices\u2013the use of the USP III apparatus","volume":"104","author":"Asare-Addo","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.06.023_bib0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2004.04.016","article-title":"Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices\u2013influence of agitation rate and dissolution medium composition","volume":"279","author":"Kavanagh","year":"2004","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2024.06.023_bib0010","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1021\/acs.molpharmaceut.9b01025","article-title":"Insights into the dissolution behavior of Ledipasvir-Copovidone amorphous solid dispersions: role of drug loading and intermolecular interactions","volume":"16","author":"Que","year":"2019","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.023_bib0011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/acs.molpharmaceut.1c00481","article-title":"Balancing solid-state stability and dissolution performance of lumefantrine amorphous solid dispersions: the role of polymer choice and drug-polymer interactions","volume":"19","author":"Hiew","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.06.023_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105514","article-title":"Patterns of drug release as a function of drug loading from amorphous solid dispersions: a comparison of five different polymers","volume":"155","author":"Saboo","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.06.023_bib0013","article-title":"Quantification of Soluplus\u00ae and copovidone polymers in dissolution media: critical systematic review","volume":"89","author":"Horv\u00e1th","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2024.06.023_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051044","article-title":"A hot-melt extrusion risk assessment classification system for amorphous solid dispersion formulation development","volume":"14","author":"Kyeremateng","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.023_bib0015","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/app.1972.070161109","article-title":"Salt effect on gel permeation chromatography of partially charged polymers","volume":"16","author":"Coppola","year":"1972","journal-title":"J Appl Polym Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.023_bib0016","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/03639045.2015.1104347","article-title":"Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions","volume":"42","author":"Lu","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2024.06.023_bib0017","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cherd.2023.04.011","article-title":"A high throughput approach of selecting excipients for solubility enhancement of BCS Class II active pharmaceutical ingredients for oral dosage forms","volume":"193","author":"Bahr","year":"2023","journal-title":"Chem Eng Res Design"},{"issue":"10","key":"10.1016\/j.xphs.2024.06.023_bib0018","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3390\/pharmaceutics14102228","article-title":"Revisiting the dissolution of praziquantel in biorelevant media and the impact of digestion of milk on drug dissolution","volume":"14","author":"Eason","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2024.06.023_bib0019","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.xphs.2016.03.024","article-title":"Non-sink dissolution conditions for predicting product quality and in vivo performance of supersaturating drug delivery systems","volume":"105","author":"Sun","year":"2016","journal-title":"J Pharm Sci"},{"issue":"15","key":"10.1016\/j.xphs.2024.06.023_bib0020","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1039\/C6RA26629K","article-title":"Investigation of pseudo-polyanion formation between polyvinylpyrrolidone and sodium dodecanoate in aqueous solution by capillary electrophoresis, conductometry, tensiometry and calcium stability","volume":"7","author":"Wu","year":"2017","journal-title":"RSC Adv"},{"issue":"16","key":"10.1016\/j.xphs.2024.06.023_bib0021","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1021\/la049348o","article-title":"Effect of ethanol on the interaction between poly(vinylpyrrolidone) and sodium dodecyl sulfate","volume":"20","author":"Griffiths","year":"2004","journal-title":"Langmuir"},{"issue":"3\u20134","key":"10.1016\/j.xphs.2024.06.023_bib0022","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jcrysgro.2003.09.019","article-title":"Crystallization habit of calcium carbonate in presence of sodium dodecyl sulfate and\/or polypyrrolidone","volume":"260","author":"Wei","year":"2004","journal-title":"J Cryst Growth"},{"key":"10.1016\/j.xphs.2024.06.023_bib0023","unstructured":"Waters. ACQUITY UPLS protein BEH SEC columns and standards. www.waters.com\/webassets\/cms\/support\/docs\/720003385en.pdf"},{"key":"10.1016\/j.xphs.2024.06.023_bib0024","series-title":"Guidance for Industry","year":"2024"},{"key":"10.1016\/j.xphs.2024.06.023_bib0025","unstructured":"Waters. XBridge protein BEH SEC columns and standards. www.waters.com\/webassets\/cms\/support\/docs\/720005206en.pdf"},{"issue":"6","key":"10.1016\/j.xphs.2024.06.023_bib0026","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/chrsci\/49.6.457","article-title":"Determination of total polyvinylpyrrolidone (PVP) in ophthalmic solutions by size exclusion chromatography with ultraviolet\u2013visible detection","volume":"49","author":"Tavlarakis","year":"2011","journal-title":"J Chromatogr Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.06.023_bib0027","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/cr200182j","article-title":"Artifacts in liquid-phase separations-system, solvent, and impurity peaks","volume":"112","author":"Buszewski","year":"2012","journal-title":"Chem Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T01:35:13Z","timestamp":1734744913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022354924002454"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.06.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of soluplus for dissolution tests: SEC method development and validation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}